iPath Pure Beta Sugar ETN
SGAR
SGAR was delisted on the 11th of April, 2018.
2 hedge funds and large institutions have $41K invested in iPath Pure Beta Sugar ETN in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
33% less funds holding
Funds holding: 3 → 2 (-1)
89% less capital invested
Capital invested by funds: $358K → $41K (-$317K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$6.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$320K |
SGAR Hedge Fund Activity: Q2 2017 in Review
2 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Sugar ETN (SGAR) for Q2 2017, worth a combined $41K — down 89% from $358K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SGAR and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $6.38K. The largest seller was Jane Street, exiting entirely with an estimated $320K sold.
- 2 institutional investors held iPath Pure Beta Sugar ETN (SGAR) as of Q2 2017, down from 3 in Q1 2017.
- Funds reported $41K of iPath Pure Beta Sugar ETN stock for Q2 2017, down 89% quarter-over-quarter.
- 0 funds opened new iPath Pure Beta Sugar ETN positions in Q2 2017 and 1 closed out, a net change of -1 holder.
- The largest iPath Pure Beta Sugar ETN buyer in Q2 2017 was UBS Group, an estimated $6.38K added.
- The largest iPath Pure Beta Sugar ETN seller in Q2 2017 was Jane Street, an estimated $320K sold.
Based on aggregated 13F filings for Q2 2017.